FindTrial
Sign In

muromonab-CD3

BIOLOGICAL9 trials

Sponsors

St. Vincent Medical Center - Los Angeles, University of Colorado, Denver, National Cancer Institute (NCI), Barbara Ann Karmanos Cancer Institute, Mayo Clinic

Conditions

Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersGiant Cell MyocarditisGraft Versus Host DiseaseKidney CancerLeukemiaLymphomaMelanoma (Skin)

Phase 1

Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
NCT00002482
St. Vincent Medical Center - Los AngelesUnspecified Adult Solid Tumor, Protocol Specific
Start: 1991-06-30Updated: 2013-11-06
Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors
CompletedNCT00002572
University of Colorado, DenverBrain and Central Nervous System Tumors
Start: 1994-11-30End: 1999-12-31Target: 10Updated: 2013-05-30

Phase 2

Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
CompletedNCT00004482
Mayo ClinicGiant Cell Myocarditis, Myocarditis
Start: 1999-12-31End: 2006-07-31Target: 40Updated: 2010-09-09
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
CompletedNCT00004024
Barbara Ann Karmanos Cancer InstituteBrain and Central Nervous System Tumors
Start: 1997-06-30End: 2004-01-31Target: 60Updated: 2013-04-05
Lymphocyte Therapy in Treating Patients With Kidney Cancer
NCT00002589
National Cancer Institute (NCI)Kidney Cancer
Start: 1994-07-31Target: 90Updated: 2013-12-18
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
TerminatedNCT00005852
H. Lee Moffitt Cancer Center and Research InstituteChronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia +3
Start: 1996-06-30End: 2007-07-31Updated: 2012-12-11
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
CompletedNCT00004022
Barbara Ann Karmanos Cancer InstituteMelanoma (Skin)
Start: 1997-06-30End: 2004-01-31Updated: 2013-04-05
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
TerminatedNCT00450983
Fred Hutchinson Cancer CenterGraft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
Start: 2006-12-31End: 2010-07-31Updated: 2017-05-24

Unknown Phase

Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
CompletedNCT00027443
Mayo ClinicMyocarditis
Start: 2001-08-31End: 2007-07-31Target: 40Updated: 2015-03-25